DK170187B1 - Fremgangsmåde til bestemmelse af indholdet af ligevægts-iod i en vandig opløsning af en iodofor samt et kimdræbende middel indeholdende en vandig opløsning af povidon-iod og en iodatforbindelse i opløsning - Google Patents

Fremgangsmåde til bestemmelse af indholdet af ligevægts-iod i en vandig opløsning af en iodofor samt et kimdræbende middel indeholdende en vandig opløsning af povidon-iod og en iodatforbindelse i opløsning Download PDF

Info

Publication number: DK170187B1
Authority: DK; Denmark
Prior art keywords: iodine; solution; equilibrium; amount; iodophore
Prior art date: 1984-05-31

Application number

DK242185A

Other languages

Danish (da)

English (en)

Other versions

DK242185A (da

DK242185D0 (da

Inventor

William Pollack

Oliver Iny

Original Assignee

Euro Celtique Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-05-31

Filing date

1985-05-30

Publication date

1995-06-06

1985-05-30 Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa

1985-05-30 Publication of DK242185D0 publication Critical patent/DK242185D0/da

1985-12-01 Publication of DK242185A publication Critical patent/DK242185A/da

1995-06-06 Application granted granted Critical

1995-06-06 Publication of DK170187B1 publication Critical patent/DK170187B1/da

Links

229910052740 iodine Inorganic materials 0.000 title claims abstract description 412
239000011630 iodine Substances 0.000 title claims abstract description 411
239000000243 solution Substances 0.000 title claims abstract description 244
230000002070 germicidal effect Effects 0.000 title claims abstract description 63
239000007864 aqueous solution Substances 0.000 title claims abstract description 20
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 title claims abstract 26
238000000034 method Methods 0.000 title claims description 34
-1 iodate compound Chemical class 0.000 title claims description 28
CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 title claims description 24
229920000153 Povidone-iodine Polymers 0.000 title claims description 24
229960001621 povidone-iodine Drugs 0.000 title claims description 24
230000008569 process Effects 0.000 title claims description 19
239000003795 chemical substances by application Substances 0.000 title claims description 17
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims abstract description 423
239000002904 solvent Substances 0.000 claims abstract description 83
238000000605 extraction Methods 0.000 claims abstract description 49
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 33
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 24
ICIWUVCWSCSTAQ-UHFFFAOYSA-M iodate Chemical compound [O-]I(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-M 0.000 claims abstract description 12
IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical group CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 41
230000003247 decreasing effect Effects 0.000 claims description 4
230000003641 microbiacidal effect Effects 0.000 claims description 2
238000002360 preparation method Methods 0.000 abstract description 31
239000000203 mixture Substances 0.000 abstract description 12
229920000642 polymer Polymers 0.000 description 60
229920000036 polyvinylpyrrolidone Polymers 0.000 description 43
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 43
238000009826 distribution Methods 0.000 description 33
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 24
239000001267 polyvinylpyrrolidone Substances 0.000 description 24
230000000813 microbial effect Effects 0.000 description 23
238000006243 chemical reaction Methods 0.000 description 21
241000894007 species Species 0.000 description 18
WRTMQOHKMFDUKX-UHFFFAOYSA-N triiodide Chemical compound I[I-]I WRTMQOHKMFDUKX-UHFFFAOYSA-N 0.000 description 18
229940069328 povidone Drugs 0.000 description 17
238000010521 absorption reaction Methods 0.000 description 15
210000001519 tissue Anatomy 0.000 description 14
230000006870 function Effects 0.000 description 12
239000000126 substance Substances 0.000 description 12
125000000129 anionic group Chemical group 0.000 description 11
230000015572 biosynthetic process Effects 0.000 description 11
230000000694 effects Effects 0.000 description 11
206010052428 Wound Diseases 0.000 description 10
208000027418 Wounds and injury Diseases 0.000 description 10
238000005192 partition Methods 0.000 description 10
JLKDVMWYMMLWTI-UHFFFAOYSA-M potassium iodate Chemical compound [K+].[O-]I(=O)=O JLKDVMWYMMLWTI-UHFFFAOYSA-M 0.000 description 10
239000001230 potassium iodate Substances 0.000 description 10
235000006666 potassium iodate Nutrition 0.000 description 10
229940093930 potassium iodate Drugs 0.000 description 10
229940006158 triiodide ion Drugs 0.000 description 10
230000007423 decrease Effects 0.000 description 9
230000009918 complex formation Effects 0.000 description 8
238000004132 cross linking Methods 0.000 description 8
238000012360 testing method Methods 0.000 description 8
230000003993 interaction Effects 0.000 description 6
230000003287 optical effect Effects 0.000 description 6
229920000620 organic polymer Polymers 0.000 description 6
239000007800 oxidant agent Substances 0.000 description 6
230000008929 regeneration Effects 0.000 description 6
238000011069 regeneration method Methods 0.000 description 6
241000283973 Oryctolagus cuniculus Species 0.000 description 5
206010040880 Skin irritation Diseases 0.000 description 5
238000007792 addition Methods 0.000 description 5
230000015556 catabolic process Effects 0.000 description 5
230000008859 change Effects 0.000 description 5
238000000354 decomposition reaction Methods 0.000 description 5
238000006731 degradation reaction Methods 0.000 description 5
230000035784 germination Effects 0.000 description 5
150000002500 ions Chemical class 0.000 description 5
230000007794 irritation Effects 0.000 description 5
230000002147 killing effect Effects 0.000 description 5
239000008213 purified water Substances 0.000 description 5
239000012488 sample solution Substances 0.000 description 5
230000036556 skin irritation Effects 0.000 description 5
231100000475 skin irritation Toxicity 0.000 description 5
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 4
238000004458 analytical method Methods 0.000 description 4
238000010668 complexation reaction Methods 0.000 description 4
238000010494 dissociation reaction Methods 0.000 description 4
229940005633 iodate ion Drugs 0.000 description 4
XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 4
230000009467 reduction Effects 0.000 description 4
239000007787 solid Substances 0.000 description 4
231100000331 toxic Toxicity 0.000 description 4
230000002588 toxic effect Effects 0.000 description 4
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
230000001476 alcoholic effect Effects 0.000 description 3
150000001450 anions Chemical class 0.000 description 3
230000002421 anti-septic effect Effects 0.000 description 3
239000008346 aqueous phase Substances 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
230000006378 damage Effects 0.000 description 3
239000002274 desiccant Substances 0.000 description 3
239000003599 detergent Substances 0.000 description 3
238000010790 dilution Methods 0.000 description 3
239000012895 dilution Substances 0.000 description 3
238000002845 discoloration Methods 0.000 description 3
230000005593 dissociations Effects 0.000 description 3
150000002496 iodine Chemical class 0.000 description 3
244000005700 microbiome Species 0.000 description 3
230000003647 oxidation Effects 0.000 description 3
238000007254 oxidation reaction Methods 0.000 description 3
239000012071 phase Substances 0.000 description 3
NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
102000004169 proteins and genes Human genes 0.000 description 3
108090000623 proteins and genes Proteins 0.000 description 3
230000000717 retained effect Effects 0.000 description 3
239000000523 sample Substances 0.000 description 3
FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
239000004094 surface-active agent Substances 0.000 description 3
238000004448 titration Methods 0.000 description 3
231100000419 toxicity Toxicity 0.000 description 3
230000001988 toxicity Effects 0.000 description 3
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
230000009471 action Effects 0.000 description 2
230000002776 aggregation Effects 0.000 description 2
238000004220 aggregation Methods 0.000 description 2
230000032683 aging Effects 0.000 description 2
ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
239000003125 aqueous solvent Substances 0.000 description 2
230000008901 benefit Effects 0.000 description 2
238000009739 binding Methods 0.000 description 2
239000007853 buffer solution Substances 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
239000000470 constituent Substances 0.000 description 2
238000001816 cooling Methods 0.000 description 2
150000008049 diazo compounds Chemical class 0.000 description 2
230000003292 diminished effect Effects 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
239000011521 glass Substances 0.000 description 2
230000002209 hydrophobic effect Effects 0.000 description 2
230000009878 intermolecular interaction Effects 0.000 description 2
229940006461 iodide ion Drugs 0.000 description 2
239000002085 irritant Substances 0.000 description 2
231100000021 irritant Toxicity 0.000 description 2
238000012804 iterative process Methods 0.000 description 2
230000031700 light absorption Effects 0.000 description 2
239000007791 liquid phase Substances 0.000 description 2
239000000463 material Substances 0.000 description 2
238000005259 measurement Methods 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
238000002156 mixing Methods 0.000 description 2
239000000178 monomer Substances 0.000 description 2
210000004400 mucous membrane Anatomy 0.000 description 2
230000002688 persistence Effects 0.000 description 2
231100000572 poisoning Toxicity 0.000 description 2
230000000607 poisoning effect Effects 0.000 description 2
HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical group O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 2
238000011084 recovery Methods 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
239000012088 reference solution Substances 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
239000001509 sodium citrate Substances 0.000 description 2
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
239000001488 sodium phosphate Substances 0.000 description 2
235000011008 sodium phosphates Nutrition 0.000 description 2
229910000679 solder Inorganic materials 0.000 description 2
238000002798 spectrophotometry method Methods 0.000 description 2
DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical compound [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 2
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical class [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
230000003313 weakening effect Effects 0.000 description 2
JQMFQLVAJGZSQS-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JQMFQLVAJGZSQS-UHFFFAOYSA-N 0.000 description 1
QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 1
206010067484 Adverse reaction Diseases 0.000 description 1
XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
206010021143 Hypoxia Diseases 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
208000002193 Pain Diseases 0.000 description 1
229920003081 Povidone K 30 Polymers 0.000 description 1
229920003082 Povidone K 90 Polymers 0.000 description 1
206010040829 Skin discolouration Diseases 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
OBOXTJCIIVUZEN-UHFFFAOYSA-N [C].[O] Chemical group [C].[O] OBOXTJCIIVUZEN-UHFFFAOYSA-N 0.000 description 1
ZHGVBKGHGOWFOG-UHFFFAOYSA-N [I].CCCCCCC Chemical compound [I].CCCCCCC ZHGVBKGHGOWFOG-UHFFFAOYSA-N 0.000 description 1
SWJBITNFDYHWBU-UHFFFAOYSA-N [I].[I] Chemical compound [I].[I] SWJBITNFDYHWBU-UHFFFAOYSA-N 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
239000003929 acidic solution Substances 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000002411 adverse Effects 0.000 description 1
230000006838 adverse reaction Effects 0.000 description 1
125000001931 aliphatic group Chemical group 0.000 description 1
239000012670 alkaline solution Substances 0.000 description 1
229910001870 ammonium persulfate Inorganic materials 0.000 description 1
239000003945 anionic surfactant Substances 0.000 description 1
239000000729 antidote Substances 0.000 description 1
239000012736 aqueous medium Substances 0.000 description 1
238000003556 assay Methods 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
239000013060 biological fluid Substances 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
238000006664 bond formation reaction Methods 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
239000003093 cationic surfactant Substances 0.000 description 1
239000003638 chemical reducing agent Substances 0.000 description 1
229940125846 compound 25 Drugs 0.000 description 1
230000008094 contradictory effect Effects 0.000 description 1
230000034994 death Effects 0.000 description 1
231100000517 death Toxicity 0.000 description 1
230000001066 destructive effect Effects 0.000 description 1
238000001514 detection method Methods 0.000 description 1
238000007865 diluting Methods 0.000 description 1
208000018459 dissociative disease Diseases 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
238000005530 etching Methods 0.000 description 1
IIEWJVIFRVWJOD-UHFFFAOYSA-N ethyl cyclohexane Natural products CCC1CCCCC1 IIEWJVIFRVWJOD-UHFFFAOYSA-N 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
230000037406 food intake Effects 0.000 description 1
235000011389 fruit/vegetable juice Nutrition 0.000 description 1
229910052736 halogen Inorganic materials 0.000 description 1
125000005843 halogen group Chemical group 0.000 description 1
150000002367 halogens Chemical class 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
229920001519 homopolymer Polymers 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
230000007954 hypoxia Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
238000011835 investigation Methods 0.000 description 1
150000004694 iodide salts Chemical class 0.000 description 1
150000002497 iodine compounds Chemical class 0.000 description 1
125000002346 iodo group Chemical group I* 0.000 description 1
150000002605 large molecules Chemical class 0.000 description 1
239000007788 liquid Substances 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000002184 metal Substances 0.000 description 1
229910001511 metal iodide Inorganic materials 0.000 description 1
230000002906 microbiologic effect Effects 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
239000002736 nonionic surfactant Substances 0.000 description 1
230000009965 odorless effect Effects 0.000 description 1
238000000424 optical density measurement Methods 0.000 description 1
150000002894 organic compounds Chemical class 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
230000001590 oxidative effect Effects 0.000 description 1
231100000915 pathological change Toxicity 0.000 description 1
230000036285 pathological change Effects 0.000 description 1
230000037361 pathway Effects 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
235000021317 phosphate Nutrition 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
230000006461 physiological response Effects 0.000 description 1
239000002798 polar solvent Substances 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000000843 powder Substances 0.000 description 1
239000002243 precursor Substances 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
QGKLPGKXAVVPOJ-UHFFFAOYSA-N pyrrolidin-3-one Chemical group O=C1CCNC1 QGKLPGKXAVVPOJ-UHFFFAOYSA-N 0.000 description 1
239000002994 raw material Substances 0.000 description 1
230000001172 regenerating effect Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
230000037370 skin discoloration Effects 0.000 description 1
235000009518 sodium iodide Nutrition 0.000 description 1
239000012064 sodium phosphate buffer Substances 0.000 description 1
239000008279 sol Substances 0.000 description 1
238000010186 staining Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
230000002195 synergetic effect Effects 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
231100000057 systemic toxicity Toxicity 0.000 description 1
229920001864 tannin Polymers 0.000 description 1
239000001648 tannin Substances 0.000 description 1
235000018553 tannin Nutrition 0.000 description 1
239000012085 test solution Substances 0.000 description 1
239000004753 textile Substances 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
125000003396 thiol group Chemical group [H]S* 0.000 description 1
230000036962 time dependent Effects 0.000 description 1
230000000451 tissue damage Effects 0.000 description 1
231100000827 tissue damage Toxicity 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
230000009466 transformation Effects 0.000 description 1
238000004804 winding Methods 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/12—Iodine, e.g. iodophors; Compounds thereof
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/19—Halogen containing
- Y10T436/193333—In aqueous solution
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
- Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Landscapes

Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Agronomy & Crop Science (AREA)
Inorganic Chemistry (AREA)
Pest Control & Pesticides (AREA)
Plant Pathology (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Dentistry (AREA)
General Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Environmental Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Catching Or Destruction (AREA)
Investigating Or Analyzing Materials By The Use Of Fluid Adsorption Or Reactions (AREA)
Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)

DK242185A 1984-05-31 1985-05-30 Fremgangsmåde til bestemmelse af indholdet af ligevægts-iod i en vandig opløsning af en iodofor samt et kimdræbende middel indeholdende en vandig opløsning af povidon-iod og en iodatforbindelse i opløsning DK170187B1 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US06/615,835 US4575491A (en)	1984-05-31	1984-05-31	Method of controlling and determining germicidal activity
US61583584		1984-05-31

Publications (3)

Publication Number	Publication Date
DK242185D0 DK242185D0 (da)	1985-05-30
DK242185A DK242185A (da)	1985-12-01
DK170187B1 true DK170187B1 (da)	1995-06-06

Family

ID=24467013

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK242185A DK170187B1 (da)	1984-05-31	1985-05-30	Fremgangsmåde til bestemmelse af indholdet af ligevægts-iod i en vandig opløsning af en iodofor samt et kimdræbende middel indeholdende en vandig opløsning af povidon-iod og en iodatforbindelse i opløsning

Country Status (6)

Country	Link
US (1)	US4575491A (de)
EP (1)	EP0169320B1 (de)
AT (1)	ATE66339T1 (de)
CA (1)	CA1255226A (de)
DE (1)	DE3583833D1 (de)
DK (1)	DK170187B1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4996048A (en) *	1988-11-30	1991-02-26	Euroceltique, S.A.	Stabilizing packaged iodophor and minimizing leaching of iodine through packaging
US5252320A (en) *	1989-06-05	1993-10-12	Isp Investments Inc.	PVP-HI-I2 complexes having a partition coefficient above 300, and process for making same
WO1990014834A1 (en) *	1989-06-05	1990-12-13	Gaf Chemicals Corporation	Pvp-hi-i2 complexes having a partition coefficient above 300, and process for making same
GB9006346D0 (en) *	1990-03-21	1990-05-16	Euro Celtique Sa	Pharmaceutical composition
US5643608A (en) *	1996-03-01	1997-07-01	West Agro, Inc.	Low pH germicidal iodine compositions having enhanced stability
US6398961B1 (en)	2000-07-20	2002-06-04	Ecolab Inc.	Device and method for sensing low level iodine in aqueous solution
US6663902B1 (en)	2000-09-19	2003-12-16	Ecolab Inc.	Method and composition for the generation of chlorine dioxide using Iodo-Compounds, and methods of use
US20150305343A1 (en) *	2014-04-28	2015-10-29	American Sterilizer Company	Process and composition for killing spores
CN105865883A (zh) *	2016-03-31	2016-08-17	常州大学	一种聚维酮碘中络合的单质碘含量的测定方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3028300A (en) *	1960-09-13	1962-04-03	West Laboratories Inc	Germicidal compositions and methods for preparing the same
DE2540170C3 (de) *	1975-09-10	1979-01-18	Basf Ag, 6700 Ludwigshafen	Verwendung von in organischer Lösung hergestelltem Polyvinylpyrrolidon zur Herstellung von stabilen wäßrigen PoIyvinylpyrrolidon-Jod-Lösungen
US4113857A (en) *	1977-05-16	1978-09-12	The Purdue Frederick Company	Process for the preparation of iodophor compounds and methods for stabilizing iodophor pharmaceutical compositions containing the same
US4271149A (en) *	1979-09-21	1981-06-02	West Agro-Chemical, Inc.	Germicidal iodine compositions with enhanced iodine stability

1984
- 1984-05-31 US US06/615,835 patent/US4575491A/en not_active Expired - Lifetime
1985
- 1985-05-01 CA CA000480543A patent/CA1255226A/en not_active Expired
- 1985-05-09 EP EP85105664A patent/EP0169320B1/de not_active Expired - Lifetime
- 1985-05-09 AT AT85105664T patent/ATE66339T1/de not_active IP Right Cessation
- 1985-05-09 DE DE8585105664T patent/DE3583833D1/de not_active Expired - Lifetime
- 1985-05-30 DK DK242185A patent/DK170187B1/da not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0169320A3 (en)	1986-06-11
DK242185A (da)	1985-12-01
EP0169320B1 (de)	1991-08-21
CA1255226A (en)	1989-06-06
US4575491A (en)	1986-03-11
DK242185D0 (da)	1985-05-30
EP0169320A2 (de)	1986-01-29
ATE66339T1 (de)	1991-09-15
DE3583833D1 (de)	1991-09-26

Legal Events

Date	Code	Title	Description
2005-06-20	PUP	Patent expired

Publication	Publication Date	Title
JP2535147B2 (ja)	1996-09-18	殺菌剤組成物
Gottardi	2001	Iodine and iodine compounds
Debnam et al.	1975	An experimental method of identifying and quantifying the active transfer electrogenic component from the diffusive component during sugar absorption measured in vivo.
NO753778L (de)	1976-05-18
Leypoldt et al.	1995	Ultrafiltration and solute kinetics using low sodium peritoneal dialysate
US4946673A (en)	1990-08-07	Iodine-containing germicidal preparations and method of controlling germicidal activity
CH639492A5 (fr)	1983-11-15	Sang etalon de controle et procede de sa preparation.
US4575491A (en)	1986-03-11	Method of controlling and determining germicidal activity
Piwnica-Worms et al.	1985	Potassium-chloride cotransport in cultured chick heart cells
Lenfant et al.	1965	Oxygen uptake and change in carbon dioxide tension in human blood stored at 37 C
DE69106990T2 (de)	1995-09-28	Poviden-Jod enthaltende pharmazeutische Zubereitung.
Kwant et al.	1970	The erythrocyte ghost is a perfect osmometer
JPH04217628A (ja)	1992-08-07	医薬ヨウ素組成物
JP2008510578A (ja)	2008-04-10	血液サンプルの凝固の低減
EP0120301B1 (de)	1990-05-16	Verfahren zur Herstellung von standardisierten Iodophorpräparaten und solche Präparate
RU2226093C1 (ru)	2004-03-27	Кардиоплегический раствор "инфузол"
CN114894675B (zh)	2024-04-19	一种农药助剂在植物叶片表面渗透行为的比较方法
Kondo et al.	1987	Effect of glutaraldehyde on renal tubular function: II. Selective inhibition of Cl− transport in the hamster thin ascending limb of Henle's loop
Farmer et al.	1939	Organic anions of human erythrocytes
JPS6310732A (ja)	1988-01-18	血液保存用組成物
CN116135021A (zh)	2023-05-19	杀菌组成物
RU2837538C1 (ru)	2025-04-01	Криопротектор для цельной крови при низкотемпературной заморозке
Pollock et al.	1975	Studies on the effects of ββ'-iminodipropionitrile and o-(β-hydroxyethyl)-rutoside on ADP-activated aggregation of rat platelets in relation to the development of diabetic microangiopathy
Hahn	1989	Dilution of blood proteins due to irrigant absorption in transurethral prostatic resection
Jones	2002	On the Existence and Behavior of Complex Polyiodides